Species Differences in Human and Rat Islet Sensitivity to Human Cytokines. Monoclonal Anti-interleukin-1 (IL-1) Influences on Direct and Indirect IL-1-mediated Islet Effects
Overview
Authors
Affiliations
Species differences in sensitivity to human recombinant cytokines were observed when human or rat islets were co-cultured with human recombinant cytokines for 6 days. Suppression of both human and rat islet insulin secretion resulted from co-culture with recombinant interleukin-1 alpha (rIL-1 alpha) or interleukin-1 beta (rIL-1 beta); however, direct rIL-1 alpha and rIL-1 beta cytotoxicity was seen with rat islets but not with human islets. Human islet insulin secretion was also suppressed during co-culture with recombinant tumor necrosis factor (rTNF) or interferon (rIFN), but not with lymphotoxin (rLT) or rIL-6; rat islet insulin secretion was not suppressed by any of these cytokines. No direct cytotoxic effects resulted from co-culture of human islets with rLT, rTNF, rIFN, or rIL-6; rLT was slightly cytotoxic for rat islets. Human islet cytotoxic synergy occurred between rLT and rIL-1 alpha, rIL-1 beta, or rIFN; synergy in suppression of human islet insulin secretion occurred between rLT and rIL-1 beta, and between rIFN and rTNF. Pretreatment of rIL-1 with monoclonal antibody (mAb) specific for non-crossreactive epitopes on rIL-1 alpha (H43 and H12) or rIL-1 beta (H34 and H21) prevented islet cytotoxic synergy between rIL-1 alpha or rIL-1 beta, respectively, and rLT. Although all four mAb's neutralize the thymocyte and fibroblast stimulatory activities of rIL-1 alpha or rIL-1 beta, mAb H21 does not neutralize rIL-1 beta activity against rat islets. Implications for cytokine-mediated islet cytotoxicity and suppression of insulin secretion are discussed.
Lymphotoxins Serve as a Novel Orchestrator in T1D Pathogenesis.
Liu S, Sun F, Rong S, Wang T, Wang C Front Immunol. 2022; 13:917577.
PMID: 35757751 PMC: 9219589. DOI: 10.3389/fimmu.2022.917577.
Use of human islets to understand islet biology and diabetes: progress, challenges and suggestions.
Hart N, Powers A Diabetologia. 2018; 62(2):212-222.
PMID: 30547228 PMC: 6325002. DOI: 10.1007/s00125-018-4772-2.
Nunemaker C J Diabetes Res. 2016; 2016:2846570.
PMID: 27843953 PMC: 5097812. DOI: 10.1155/2016/2846570.
Sensitivity profile of the human EndoC-βH1 beta cell line to proinflammatory cytokines.
Gurgul-Convey E, Mehmeti I, Plotz T, Jorns A, Lenzen S Diabetologia. 2016; 59(10):2125-33.
PMID: 27460666 DOI: 10.1007/s00125-016-4060-y.
Farnsworth N, Walter R, Hemmati A, Westacott M, Benninger R J Biol Chem. 2015; 291(7):3184-96.
PMID: 26668311 PMC: 4751367. DOI: 10.1074/jbc.M115.679506.